Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients

Elimor Brand-Schieber,1 Sagar Munjal,1 Rajesh Kumar,1 Anthony D Andre,2 Will Valladao,2 Margarita Ramirez2 1Dr. Reddy’s Laboratories Inc., Princeton, NJ, 2Interface Analysis Associates, Saratoga, CA, USA Background: Migraine pain relief is reported by more than 50% of patients who receive...

Full description

Saved in:
Bibliographic Details
Main Authors: Brand-Schieber E, Munjal S, Kumar R, Andre AD, Valladao W, Ramirez M
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
Online Access:https://doaj.org/article/a2eb8fb1d91640138c1c1af8a4b6abbc
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items